Supozitoare

Quick links to important sections

Supozitoare

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Supozitoare

What is Supozitoare? Definitional Overview

Property Description
Active Ingredient Glycerol (Glycerin)
Form Rectal Suppository
Pharmacological Class Osmotic Laxative
Common Use Facilitating Bowel Evacuation
Origin Derived (Purified trihydroxy alcohol)

What is Supozitoare and Its Primary Classification?

Supozitoare is the medical designation for a rectal suppository, a solid dosage form precisely engineered for local insertion into the lower bowel. This preparation is classified as a Laxative, operating specifically as an Osmotic laxative, a class defined by its ability to increase fluid retention in the colon. Its primary function is to aid in the bowel evacuation process.

The Glycerol suppository is differentiated by its form and route, establishing it as a locally acting medication with a non-systemic function; its effect is concentrated directly in the rectum and lower colon without significant absorption into the general bloodstream. This specific administration route makes it distinct from oral osmotic agents, allowing for a focused and typically rapid onset of effect.


Composition: Active Ingredient and Mechanism Principle

The active ingredient in this single-ingredient product is Glycerol (Glycerin), a purified trihydroxy alcohol and a hygroscopic substance with a chemical affinity for water. This core property defines the drug's mechanism.

Glycerol works via osmosis, a process that draws water from surrounding tissues into the rectal space. Glycerol is the pharmacological agent utilized for its osmotic and emollient properties in treating difficulty with defecation. For the patient, this medicine helps by physically attracting moisture to the solid waste material, ensuring stool softening. The combination of hydration and the suppository base's lubricating effect is key to its action.


What is the General Therapeutic Purpose of Glycerol Suppositories?

The general therapeutic purpose of the Glycerol suppository is to provide a reliable, rapid, and non-systemic method for aiding the elimination of accumulated waste material. Due to its targeted, localized application, the suppository format is typically used for scenarios that require quick relief or the initiation of a predictable emptying process. By promoting the gentle onset of a natural reflex through physical means, the Supozitoare serves to quickly achieve the fundamental aim of efficient bowel evacuation.

Regulatory References

  1. Glycerin Suppository - DailyMed (NIH)

What side effects are possible with Supozitoare?

Possible side effects and safety information

The safety profile of the Glycerol suppository (Supozitoare) is primarily defined by its localized action, meaning most documented effects occur at the site of administration in the lower bowel. These effects are officially categorized under Gastrointestinal Disorders and General Disorders and Administration Site Conditions.


Officially Documented Adverse Reactions

The frequency of adverse reactions for this non-systemic product is generally classified as Not Known, as specific rates cannot be estimated from the available data. Adverse reactions explicitly listed in regulatory documents include rectal discomfort, a burning sensation, and local irritation.

Classification Examples of Officially Listed Adverse Reactions
Administration Site Rectal irritation, burning, or discomfort.
Gastrointestinal Abdominal cramps or mild discomfort.

Serious Safety Considerations and Restrictions

Official labeling documents specific safety considerations and high-level constraints on use. Serious adverse reactions that warrant discontinuing use include rectal bleeding or the failure to have a bowel movement after product administration, which may indicate an underlying condition.

Safety Restrictions

The medication must not be used in the presence of certain concurrent symptoms, specifically undiagnosed abdominal pain, nausea, or vomiting. Use is also contraindicated in individuals with known conditions such as intestinal obstruction or fecal impaction.

Duration and Population Safety

The product is intended for occasional use. Regulatory documentation advises against its use for longer than one week. Regarding specific groups, use in children under 2 years is subject to specific medical guidance, as noted in the FDA labeling.

Overdose and Emergency Response

The official regulatory profile for Supozitoare (Glycerol suppositories) focuses on the documented clinical manifestations that may occur following the accidental swallowing of a large number of the product, as the medication is classified as locally acting.

Documented Overdose Presentations

Documented manifestations associated with this exposure include common symptoms such as headache, nausea, and vomiting. Less frequent manifestations documented in the regulatory labeling include diarrhea, thirst, dizziness, and mental confusion. The physiological systems potentially affected include the cardiovascular system, where irregular heartbeat is listed as a possible, less frequent outcome of significant accidental ingestion.

Required Emergency Actions

Regulatory guidance specifies that immediate medical attention is required if the product is swallowed. The mandated action is to seek medical help or contact a Poison Control Center right away. This action is required to manage the documented systemic risks associated with large accidental ingestion.

Separate guidance instructs users to stop use and ask a doctor if specific local complications occur. These required help-seeking triggers are the occurrence of rectal bleeding or the failure to have a bowel movement after using the product, which may indicate a serious underlying condition.

The regulatory documents do not specify a known antidote for this product. Furthermore, for minimal accidental exposure, active medical measures are generally documented as unlikely to be needed.

Therapeutic Uses of Supozitoare

The Glycerol Suppository is commonly used to provide localized support in managing the symptoms of lower bowel discomfort, focusing exclusively on acute and temporary symptomatic relief. This medication is utilized for the relief of occasional constipation.


Symptom Relief and Therapeutic Focus

The medication is applied in addressing symptom clusters that may become intense or disruptive, such as symptoms related to physical discomfort associated with hard stools, infrequent movements, and straining during defecation. Its therapeutic purpose is relevant for conditions characterized by periods of heightened symptoms, specifically occasional and acute constipation.

The localized action assists with maintaining functional stability by supporting the easier passage of waste material. This treatment is commonly used when short-term symptomatic assistance is needed in adults, children, and older adults. It is also applied in scenarios where the use of an oral product may not be feasible.

The medication may be used as supportive symptomatic relief during episodes of acute or episodic difficulty in elimination.


Quick Fact: Relief for Occasional Constipation

Quick Fact: Relief for Occasional Constipation
Primary Indication Occasional and acute constipation.
Symptom Focus Hard stools, straining, infrequent movements.
Core Benefit Provides support that helps ease the overall symptom burden and contributes to easing the overall symptom load.
Use Context Is relevant when supportive symptomatic management is appropriate during a period of temporary functional stress.

Regulatory References

  1. Label: GLYCERIN suppository - DailyMed

Eligibility and Restrictions for Use

Who Can and Cannot Use Supozitoare?

Eligibility for the Glycerol Suppository (Supozitoare) is determined by official regulatory labeling, focusing on age and specific gastrointestinal health status. Use is categorized into approved, conditional, and contraindicated populations.


Populations That Cannot Use (Contraindications)

The medicine is formally contraindicated and must not be used by patients with a known hypersensitivity to glycerol or with acute gastrointestinal conditions, including intestinal obstruction, bowel blockage, or undiagnosed acute abdominal pain.


Age-Specific Eligibility

Age Group Eligibility Status (Regulatory Basis)
Adults and Older Adults Approved for standard use.
Children 6 Years and Over Approved for standard use (specific formulations).
Children Under 2 Years Restricted Use: Requires consultation with a physician.

Conditional Use and Restrictions

Use is restricted in individuals with certain coexisting conditions. Patients with diabetes, hemorrhoids, anal fissures, or those who have experienced a sudden change in bowel habits lasting over two weeks must consult a doctor prior to use.

Regarding life stages, use is generally advised against during the first trimester of pregnancy, though it is documented as permissible during breastfeeding.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile for Supozitoare (Glycerol suppository) is highly restricted due to its non-systemic mode of action. As established in regulatory documents, the active ingredient, Glycerol, is minimally absorbed into the bloodstream; consequently, it does not participate in major metabolic pathways like the cytochrome P450 (CYP) enzyme system, nor does it affect systemic drug transporters.

Absence of Systemic Drug Interactions

Official prescribing information confirms there are no documented pharmacokinetic drug-drug interactions with systemically absorbed oral or injectable medicines. Therefore, no adjustments or special timing rules are noted for co-administration with routine systemic medications. Additionally, no interactions with food, alcohol, or herbal products are explicitly documented in regulatory labels.

Local Administration Restrictions

The sole documented interaction is based on the route of administration, classified as a physical interference interaction. This localized restriction pertains to the co-administration of other rectally administered medicinal products, such as other suppositories or enemas. To avoid potential physical interference that may compromise the local action or absorption of the other product, official regulatory labels advise against the simultaneous use of other rectal preparations.

Mechanism of Action

Modulation of Central Signaling Pathways

This domain involves the active ingredient's systemic action on Cyclooxygenase (COX) enzymes after absorption into the bloodstream. By acting as an enzyme inhibitor, the drug modifies early molecular steps, reducing the synthesis of prostaglandins within the central nervous system. This process is relevant in systems where these mediators dominate, leading to the adjustment of the brain's set-point for both pain signaling and thermoregulation, influencing the subsequent systemic physiological output.

Targeted Local Stimulation of the Enteric System

The second mechanistic domain focuses on the drug's local action within the lower gastrointestinal tract. The active component directly engages sensory nerve endings or specific receptors in the colon, initiating or suppressing signaling sequences within the enteric nervous system. This targeted pathway adjustment alters the regulation of gastrointestinal muscle tone and influences fluid dynamics, initiating subsequent alterations in bowel function.

Dosage and Administration Information

Administration Guidelines for Rectal Suppositories

This section outlines the procedural steps and dosing rules for the rectal route.

Administration Scope Details
Route of Administration Rectal Insertion Only.
Dosing Schedule Dosage is specific to the product and medical condition. Typical dosing is one suppository, once daily. Do not exceed the maximum daily dose specified on the product label.
Timing in Relation to Meals Not directly applicable to the rectal route. For laxative suppositories, the effect generally occurs within 15 to 60 minutes after insertion.
Preparation Requirements Remove the foil or plastic wrapper completely before use. If the suppository is too soft, chill it briefly in the refrigerator to harden. Moisten the tip with water or a water-based lubricating jelly; do not use petroleum jelly (e.g., Vaseline) as this can prevent the medication from melting and absorbing properly.
Age-Group Rules Adults: Insert approximately 1 inch past the muscular sphincter. Children: Use as directed by a healthcare professional; the insertion depth is typically 1/2 to 1 inch, depending on the child's size.
Missed-Dose Rules If the product is used on a scheduled basis and a dose is missed, administer it as soon as it is remembered. If it is almost time for the next scheduled dose, skip the missed dose and return to the regular schedule. Do not use two suppositories at the same time to compensate for a missed dose.

Procedural Steps

The administration method is Insertion with a frequency pattern defined by the specific product (e.g., Daily or As-needed).

  1. Hand Hygiene: Wash hands thoroughly with soap and water before beginning the procedure.
  2. Positioning: Lie on one side with the lower leg straight and the upper leg bent toward the stomach, or assume a comfortable, stable position for insertion.
  3. Insertion: Gently insert the suppository, pointed end first, with a finger. The goal is to push the suppository past the muscular opening (sphincter) of the rectum to ensure retention and absorption.
  4. Retention: Remain lying down or still for at least 5 to 20 minutes (time varies by product) to prevent the suppository from being expelled and to allow the medication to melt.
  5. Final Hygiene: Wash hands again with soap and water.

This sequence establishes the conditions for proper drug delivery, focusing on hygiene, lubrication (water-based only), correct anatomical placement, and a period of stillness to achieve the intended therapeutic exposure.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Supozitoare

The role of glycerol suppositories used in research exploring how symptoms change over time related to occasional difficulty with bowel evacuation was observed in research dating back many decades. Because the product has a long history of use, much of the foundational evidence relies on historical data and post-marketing experience reviewed by regulatory agencies. This type of regulatory evidence contributes to the regulatory evidence base for the suppository's short-term, occasional use that was studied for the general adult and pediatric populations.

Research has explored the product's function in trials that included comparisons to other agents. These comparative trials and non-placebo controlled efficacy assessments focus on outcomes related to physical discomfort during evacuation. Specifically, studies have monitored the time to first bowel movement, along with functional assessments that research described as outcomes related to straining during defecation and measurements of stool consistency.


Evidence in Specialized Pediatric and Neonatal Research

Studies also include research focused on highly specialized and vulnerable populations, primarily within hospital settings. The suppository was evaluated in research exploring its role in conditions associated with acute or disruptive episodes, particularly in preterm infants and Very Low Birth Weight (VLBW) neonates. These research scenarios involved Randomized Controlled Trials (RCTs) with small sample sizes and subsequent Systematic Reviews.

Researchers examined outcomes related to systemic or functional imbalance, such as the time required for the infant to achieve full enteral feeds (FEF) and assessments of serious gastrointestinal events. Findings were mixed across these specialized studies. While some trials reported how symptoms evolved in the observed populations, systematic reviews and meta-analyses did not consistently report significant differences in critical clinical outcomes. This research highlights the complexity of measuring effect in such vulnerable groups.

Specialized Use in Motility Assessment Research

The agent was also evaluated in specific clinical physiology studies focused on monitoring colonic motor response. This research explored the suppository's role during diagnostic procedures, such as manometry. Studies report patterns related to the High-Amplitude Propagating Contractions (HAPCs), which are physiological measurements of colonic activity. This research provides context for understanding the function of the lower bowel, but the results apply only to the populations studied in the specialized, diagnostic research context.


What Remains Uncertain and Research Gaps

Research exploring short-term symptom changes has not established its long-term profile for chronic management. Comparative evidence is lacking for many potential patient subgroups, and most studies are limited to outcomes describing episodic or acute changes. Therefore, while studies help show what has been observed so far for acute relief, the research provides context but not individual predictions regarding long-term response, durability, or complex clinical situations.

Key Studies & References

  1. Glycerin Suppository Labeling Information (DailyMed)

Frequently Asked Questions (FAQ)

Common questions about Supozitoare (FAQ)

Q: How quickly can someone expect to notice the effects of Supozitoare?

A: According to the official product information, the primary action is designed to be quick. Users can typically expect the product to produce a bowel movement within a relatively short timeframe, generally 15 to 60 minutes after the suppository is inserted.

Q: What should I know about Supozitoare and its use during pregnancy, based on official sources?

A: Official regulatory guidance discusses the use of the product during pregnancy. While some sources indicate the product is generally tolerated, it is documented as being best avoided during the first trimester. Consultation with a healthcare professional is necessary for guidance regarding an individual's specific situation.

Q: Is it necessary to finish the entire package of Supozitoare even if I feel better?

A: No, the product is officially classified and intended for occasional use to provide temporary relief. It is not designed to be taken continuously on a fixed regimen. The directions for use advise against exceeding the maximum duration of use.

Q: What are the general guidelines about using Supozitoare if you are elderly?

A: Official regulatory documentation indicates that the product is approved for standard use in the adult and older adult population. No specific dosage adjustment or special rules are typically noted for elderly patients in the product labeling.

Q: What happens if a dose of Supozitoare is missed?

A: Because this product is typically used as needed for temporary relief, the concept of a 'missed dose' generally does not apply to most users. For situations where it is used on a scheduled basis, official directions advise against doubling the dose to compensate for the one that was missed.

Q: Does official labeling include information on Supozitoare use while breastfeeding?

A: Yes, the official regulatory information confirms the product is documented as permissible for use during breastfeeding. As with any medication, consultation with a healthcare professional is generally appropriate.

Q: What is the general feeling or expectation when using Supozitoare?

A: Because the product acts locally in the lower bowel, official documentation notes that users may experience a localized sensation during the onset of action. This is often described as a burning feeling, mild discomfort, or irritation at the administration site. These are officially listed adverse reactions.

Q: Can Supozitoare affect my ability to drive or operate machinery?

A: Official information indicates that this product is a locally-acting, non-systemic medicine with minimal absorption into the bloodstream. Therefore, it is generally not associated with effects on the central nervous system that would impact the ability to drive or operate machinery.

Q: Does using Supozitoare mean I cannot use other topical creams at the same time?

A: Official labeling restricts the simultaneous use of other rectal preparations (like enemas or other suppositories) because this could cause a physical interference interaction. This specific restriction, however, does not apply to the use of non-rectal topical creams or ointments.

Q: Are there any known long-term safety concerns documented for Supozitoare?

A: The product is officially designated for occasional use, and patients are advised against using it for longer than one week. Research exploring short-term changes has not established its long-term profile for chronic management, which is why restrictions on duration of use are in place.

Q: What is the general recommended duration for using Supozitoare?

A: Regulatory documentation classifies the product for occasional use only for temporary relief. Patients are advised against using the product for a duration longer than one week unless a healthcare professional directs otherwise.

Q: Is Supozitoare a treatment that cures a condition or just helps manage symptoms?

A: The product is officially classified as an osmotic laxative intended to provide temporary relief for occasional difficulty with bowel evacuation. Its designation is to aid the process of elimination rather than to provide a cure for any underlying condition causing the difficulty.

Q: I heard Supozitoare is available over-the-counter in some places; is this true?

A: Regulatory classifications in the United States list this product as a Human OTC (Over-the-Counter) Drug product. This means that, in those regions, the product is generally available for direct purchase without the need for a prescription.

Q: What are the official warnings regarding Supozitoare use in children?

A: Official warnings advise that a healthcare provider should be consulted before use if a child has specific concurrent symptoms. These include abdominal pain, nausea, or vomiting, or if there has been a sudden change in bowel habits lasting more than two weeks.

Q: Are there specific food or beverage items that might interact with Supozitoare?

A: Regulatory labels for this non-systemic product specifically note that there are no interactions with food, alcohol, or herbal products explicitly documented. This is consistent with its localized action and minimal absorption into the bloodstream.

Q: What type of healthcare professional usually prescribes or recommends Supozitoare?

A: Because the product is classified as an Over-the-Counter (OTC) drug, it does not strictly require a prescription from a doctor. It is typically acquired directly by the user but is frequently recommended by doctors or pharmacists for temporary use.

Q: Is there a risk of becoming dependent on Supozitoare with regular use?

A: Regulatory sources caution that using the product too frequently or continually may lead to a loss of normal bowel function. This is often described as laxative dependence, where the body relies on the product for evacuation. The product is therefore intended only for occasional use.

Q: Why might a person's body react differently to Supozitoare over time?

A: The official warning against prolonged or continual use addresses the risk of the body losing its normal bowel function. If used regularly, the body may become dependent on the product for evacuation, resulting in a change in physical response over time.

Q: Are there any known drug interactions that make Supozitoare less effective?

A: The primary interaction noted in official labeling is a physical interference interaction when used at the same time as other rectal products, such as enemas or other suppositories. This type of interference could potentially compromise the local action of either product.

Q: How does the drug's purpose relate to inflammation or pain relief?

A: The product is officially classified as an osmotic laxative, and its primary regulatory function is to aid bowel evacuation. While the active ingredient may possess soothing or emollient (skin-softening) properties, its approved therapeutic purpose is not for treating inflammation or general pain relief.

Q: Why are some users saying they felt a minor burning sensation when using Supozitoare?

A: A localized burning or irritation feeling is listed as an officially documented adverse reaction under Administration Site effects. This sensation is commonly reported and is likely related to the product's localized, mild irritant action needed to help stimulate the lower bowel.

Q: Is Supozitoare known to cause any changes in mood or sleep patterns?

A: Official information suggests the product is not associated with effects on the central nervous system, such as changes in mood or sleep patterns. This is based on its classification as a locally-acting, non-systemic medicine with minimal absorption into the bloodstream.

Q: Can Supozitoare be used by people who have certain heart conditions?

A: Because the product acts locally and has minimal systemic absorption, its use is generally not restricted by systemic health conditions like heart disease. Consultation with a healthcare professional is suggested for individuals with underlying health conditions.

Q: Do I need to inform my doctor about all vitamins and supplements when using Supozitoare?

A: Official labeling does not explicitly document interactions with herbal products or supplements, reflecting the product's non-systemic action. A healthcare professional can provide the most complete guidance based on a patient's full health history and all products being used.

Q: What types of research studies have been conducted on Supozitoare?

A: Research supporting this product includes foundational studies based on historical data, comparative trials, and post-marketing experience. More specialized studies have involved Randomized Controlled Trials (RCTs) and Systematic Reviews, as well as studies focused on colonic motor response for diagnostic purposes.

Q: Does the efficacy of Supozitoare diminish with extended use?

A: Regulatory warnings advise against prolonged or continuous use, stating this can lead to a loss of normal bowel function. This suggests that the body's natural response may diminish over time, requiring external assistance for evacuation.

How should Supozitoare be stored and disposed of?

Official Storage and Disposal Requirements

The storage and disposal of Supozitoare (Glycerol Suppository) must strictly follow the conditions defined by regulatory documents to preserve product quality and safety.

Scope Item Official Regulatory Requirement
Storage Temperature Store at controlled room temperature, typically below 25 C or 30 C; do not freeze and avoid excessive heat.
Protection Must be stored in the original container and kept tightly closed to protect the suppository from moisture and light.
Child Safety Keep out of the sight and reach of children (mandatory safety instruction).
Disposal Rules Dispose of unused or expired product according to local regulatory requirements, such as medicine take-back programs. The product should generally not be flushed down a sink or toilet.

These constraints ensure the suppository maintains its integrity and stability until the expiration date, while disposal rules mandate proper discard procedures for unused medicine.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Supozitoare found in:

A-Z Index: